1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fibrin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with fibrin in 7 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (fibrin)	Trials (fibrin)	Recent Studies (post-2010) (fibrin)
9,156	187	552	15,994	328	3,808

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	1 (14.29)	18.2507
2000's	3 (42.86)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Crane, S; Johnstone, IB; Viel, L; Whiting, T	1
Levin, DL; Royall, JA	1
Aul, C; Königshausen, T; Scharf, RE; Schneider, W	1
Hayashi, J; Hiromura, K; Koizumi, R; Maezawa, A; Naruse, T; Nojima, Y; Shimizu, Y	1
Akai, T; Endo, S; Iizuka, H; Niiya, K; Sakuragawa, N	1
Farhan, S; Glogar, D; Gyöngyösi, M; Hemetsberger, H; Hemetsberger, R; Huber, K; Pavo, I; Petrasi, Z; Posa, A; Sperker, W; Strehblow, C	1
de Lima, CD; de Oliveira, AV; Machado, GB; Plotkowski, MC; Saliba, AM; Suassuna, JH	1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fibrin

Article	Year
Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. The Journal of pediatrics, 1988, Volume: 112, Issue:2 Topics: Biomechanical Phenomena; Blood Platelets; Fibrin; Fibrin Fibrinogen Degradation Products; Humans; Infant; Infant, Newborn; Oxygen; Platelet Activating Factor; Pulmonary Surfactants; Respiratory Distress Syndrome	1988

Article

Year

Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury.

The Journal of pediatrics, 1988, Volume: 112, Issue:2

Topics: Biomechanical Phenomena; Blood Platelets; Fibrin; Fibrin Fibrinogen Degradation Products; Humans; Infant; Infant, Newborn; Oxygen; Platelet Activating Factor; Pulmonary Surfactants; Respiratory Distress Syndrome

1988

Other Studies

6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fibrin

Article	Year
Hemostatic studies in racing standardbred horses with exercise-induced pulmonary hemorrhage. Hemostatic parameters at rest and after moderate exercise. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 1991, Volume: 55, Issue:2 Topics: Adenosine Diphosphate; Animals; Antithrombin III; Collagen; Factor VIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Horse Diseases; Horses; Lung Diseases; Partial Thromboplastin Time; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prothrombin Time; Thrombin Time; von Willebrand Factor	1991
[Thrombotic thrombocytopenic purpura]. Klinische Wochenschrift, 1985, Feb-04, Volume: 63, Issue:3 Topics: Blood Coagulation Factors; Blood Coagulation Tests; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fibrin; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prognosis; Purpura, Thrombotic Thrombocytopenic; Thrombosis	1985
Platelet-activating factor antagonist, SM-12502, attenuates experimental glomerular thrombosis in rats. Nephron, 2001, Volume: 87, Issue:3 Topics: Animals; Fibrin; Kidney Glomerulus; Lipopolysaccharides; Male; Neutrophil Activation; Peroxidase; Platelet Activating Factor; Rats; Rats, Wistar; Thiazoles; Thiazolidines; Thrombosis	2001
Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells. Journal of neuro-oncology, 2002, Volume: 59, Issue:3 Topics: Blotting, Northern; Brain Neoplasms; Cell Division; Culture Media, Conditioned; Enzyme-Linked Immunosorbent Assay; Fibrin; Fibrinolysis; Gene Expression Regulation, Neoplastic; Glioma; Humans; Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Platelet Activating Factor; RNA, Messenger; Tissue Plasminogen Activator; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator	2002
Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries. Coronary artery disease, 2008, Volume: 19, Issue:8 Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Animals; Aspirin; Cell Proliferation; Clopidogrel; Collagen; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Hyperplasia; Inflammation Mediators; Metals; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Swine; Ticlopidine; Time Factors; Tunica Intima	2008
Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. Respiratory research, 2011, Aug-05, Volume: 12 Topics: Animals; Bacterial Proteins; Blood Coagulation; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Disease Models, Animal; Epithelial Cells; Female; Fibrin; Humans; Immunohistochemistry; Macrophages; Mice; Mutation; Plasminogen Activator Inhibitor 1; Platelet Activating Factor; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Alveoli; Respiratory Mucosa; RNA, Messenger; Sepsis; Time Factors; Up-Regulation	2011